ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease

@inproceedings{Mouchard2019ApoEfragmentAHI,
  title={ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease},
  author={Amandine Mouchard and Marie-Charlotte Boutonnet and Claire Mazzocco and Nathalie Biendon and Nathalie Macrez},
  booktitle={Scientific Reports},
  year={2019}
}
Identification of endogenous pathological amyloid β peptides (Aβ) forms in the brains of patients with Alzheimer’s disease (AD) is still unclear. In healthy brain, Aβ can associate with Apolipoprotein E (ApoE) which is involved in its metabolism and clearance. In the brain of patients with AD, ApoE is cleaved and produces ApoE fragments. We studied the forms of Aβ and their interaction with the ApoE fragments in post-mortem brains from control and AD patients by western blots and co… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 56 REFERENCES

a new target for the prevention of amyloid deposition

Borchelt, D. R. Targeting the accomplice to thwart the culprit
  • J Clin Invest 128, 1734–1736, https://doi.org/10.1172/JCI120414 (2018). 1 1 Scientific RepoRts |
  • 2019

A Study of Abeta Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer ’ s Disease Compared to Aged Controls

A. Savioz
  • Neuro - degenerative diseases
  • 2016